Analyze Diet

Topic:Disease Treatment

Disease treatment in horses encompasses a range of medical interventions and management strategies aimed at addressing various health conditions affecting equine species. These treatments can include pharmacological approaches, such as the administration of antibiotics, anti-inflammatory drugs, and antiparasitic medications, as well as non-pharmacological methods like physical therapy, dietary adjustments, and surgical procedures. The selection of appropriate treatments depends on the specific disease, its severity, and the individual needs of the horse. This topic brings together peer-reviewed research studies and scholarly articles that explore the efficacy, safety, and advancements in therapeutic options for equine diseases, providing insights into best practices and emerging trends in equine veterinary medicine.
Proteomic signatures of equine dental tooth tissues in ageing and disease.
Equine veterinary journal    May 15, 2026   doi: 10.1002/evj.70167
Jensen A, Zambouli DE, Gringel I, Nugent Z, Yamamoto K, Cooper L, Peffers AJ, Rocchigiani G, Peffers MJ.Ageing and dental disease in horses lead to structural and functional deterioration of dental tissues, yet their molecular signatures remain poorly characterised. Understanding how these processes alter the protein composition of enamel, dentin, cementum and pulp is essential for improving equine oral health and identifying biomarkers of degeneration. Objective: To characterise the proteomic profiles of equine dental tissues and determine age- and disease-associated changes, with the aim of identifying proteins consistently altered across conditions. Methods: Ex vivo proteomic study. Methods: ...
Mitochondrial dysfunction in equine ageing: Current evidence and clinical implications for geroscience.
Equine veterinary journal    May 11, 2026   doi: 10.1002/evj.70189
Puchalska M, Witkowska-Piłaszewicz O.Ageing is a complex biological process affecting a growing geriatric human and equine population worldwide. Mitochondrial dysfunction is considered one of the hallmarks of ageing, representing a multifaceted process. This review synthesises current findings on mitochondrial dysfunction in aged equines, drawing parallels with human medicine and identifying current knowledge gaps. Integrating findings from human and equine research may bridge existing challenges and offer new opportunities, including the development of novel translational models for ageing research. Furthermore, it highlights th...
Short-term clinical responses in horses and ponies treated with canagliflozin: A clinical field study.
Equine veterinary journal    May 10, 2026   doi: 10.1002/evj.70181
Hällbom M, Lindåse ST, Wartel M, Bröjer J.Treatment with the sodium-glucose co-transporter 2 (SGLT2) inhibitor canagliflozin in insulin dysregulated (ID) horses has shown promising results in randomised clinical trials. Larger field studies are needed to further evaluate treatment responses and potential adverse effects under real-world conditions. Objective: To assess the short-term effects of canagliflozin on postprandial glucose and insulin responses in client-owned horses and ponies with ID using a single-sample feed-challenge test (FCT), and to characterise treatment-associated changes in bodyweight, liver enzyme activities, and ...
Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial.
Journal of the American Veterinary Medical Association    May 8, 2026   1-10 doi: 10.2460/javma.26.02.0098
Lowndes CR, Luethy D, Skelton G, Kulp J, Stefanovski D, van Eps AW.To evaluate bexagliflozin for insulin control in horses with naturally occurring insulin dysregulation. Unassigned: In a randomized, placebo-controlled crossover study, 10 client-owned Arabian horses with hyperinsulinemia (> 30 μIU/mL) were treated with bexagliflozin (0.03 mg/kg, PO, q 24 h; BEXA03) or placebo control for a 10-day treatment period, crossing over after a 4-day washout. After a further 12-day washout, 8 of the horses were treated with bexagliflozin (0.06 mg/kg, PO, q 24 h; BEXA06) for an additional 7-day treatment period. Oral sugar tests were performed at the beginning of e...
A novel flowable calcium silicate cement for endodontic therapy in equine teeth.
Equine veterinary journal    May 7, 2026   doi: 10.1002/evj.70176
Jackson K, Quintrell E, Staszyk C, Ha W, Kelty E, Patalwala D, Bogen G.Equine endodontic treatment for apical infections is performed infrequently due to anatomical and accessibility challenges of equine cheek teeth. However, the alternative of extraction is not without risk and lifelong implications for the horse. Mineral trioxide aggregate (MTA), a calcium silicate cement (CSC), has been used successfully in human dentistry for decades. MTA and other CSCs demonstrate excellent biocompatibility with favourable antimicrobial and physicochemical properties. These characteristics may support their application as an alternative filling material when used in equine e...
Treatment of ventricular arrhythmias with oral sotalol in four horses.
Journal of veterinary internal medicine    April 30, 2026   Volume 40, Issue 2 aalag077 doi: 10.1093/jvimsj/aalag077
Junge HK, Williams Louie EG, Mitchell KJ, Schwarzwald CC.Sustained ventricular arrhythmias (VAs) in horses can require medical intervention. Prompt pharmacological treatment is indicated when the arrhythmia leads to hemodynamic or electrical instability. Established antiarrhythmic treatment of VA in horses includes lidocaine and magnesium, administered parenterally. Other antiarrhythmic agents are used; however, concerns regarding adverse effects, financial restrictions, logistics of administration, and lack of access often limit their use. While anecdotal reports of oral administration of sotalol for treatment of VA in horses exist, sotalol has pri...
Allogeneic Platelet-Rich Gel Supernatant Reprograms the Cytokine and Growth Factor Microenvironment in an Equine In Vitro Inflammatory Tendon System.
International journal of molecular sciences    April 29, 2026   Volume 27, Issue 9 4006 doi: 10.3390/ijms27094006
Carmona JU, López C.Tendinopathy involves a dysregulated inflammatory microenvironment in which cytokines, growth factors (GF) and extracellular matrix components interact dynamically. Platelet-rich plasma (PRP) is widely used as a regenerative therapy, but its mechanisms of action in inflamed tendon remain unclear. This study evaluated whether platelet-rich gel supernatant (PRGS) reprograms the inflammatory-anabolic mediator network in an equine in vitro tendon explant system stimulated with lipopolysaccharide (LPS). Tendon explants were cultured under six experimental conditions, including non-stimulated contro...
Editorial: Biomarker identification and novel therapies in equine medicine.
Frontiers in veterinary science    April 28, 2026   Volume 13 1843968 doi: 10.3389/fvets.2026.1843968
Żak-Bochenek A, Siwińska N.No abstract available
Additional Evidence Fails to Associate Variation in KCNE4 With Equine Anhidrosis.
Animal genetics    April 27, 2026   Volume 57, Issue 3 e70109 doi: 10.1002/age.70109
Petersen JL, Finno CJ.A prior genome-wide association (GWA; N = 200) including Thoroughbreds and stock horses implicated chromosome 6 (NC_009149.3) in owner-reported equine anhidrosis. A missense variant in KCNE4 (NC_009149.3:g.11813731A>G) was proposed as a risk allele, although its association with anhidrosis was not reported. Variant annotation and protein modelling in the original study suggested the G allele conferred risk. We reported no association of the G allele with anhidrosis in 50 horses phenotyped by an intradermal terbutaline sweat test (ITST); all horses produced sweat regardless of genotype. ...
Glanders: Past, Present and Future of a Neglected Zoonosis as a Threat in Veterinary and Human Health.
Veterinary medicine and science    April 21, 2026   Volume 12, Issue 3 e70950 doi: 10.1002/vms3.70950
Kanani Y, Oryan A, Derakhshandeh A.Burkholderia mallei is the causative agent of glanders, a serious zoonotic disease of major concern for both animal and human health. This highly contagious and potentially fatal bacterium is always classified as a biothreat agent. In this review, we covered a comprehensive overview of glanders, including the biology of the pathogen, epidemiology, pathogenesis, diagnosis, control strategies and ongoing eradication programs in Eurasia. We also summarized human case reports, differential diagnosis, treatment and organism's antimicrobial properties. The section on vaccine development is among the...
Multiple strategies, one mission: mesenchymal stromal cell-based mechanisms of action in osteoarthritis.
Frontiers in cell and developmental biology    April 20, 2026   Volume 14 1763344 doi: 10.3389/fcell.2026.1763344
Junuzović M, Troillet A, Burk J.Osteoarthritis (OA) is a cross-species, multifactorial joint disease characterized by the progressive degeneration of articular cartilage, morphological remodeling of the subchondral bone, and inflammatory and fibrotic changes of the joint capsule. These alterations arise from chronic, often subclinical, inflammatory processes and dysregulated cellular homeostasis, leading to profound shifts in the cellular and extracellular composition of the joint organ. Although the mechanisms driving persistent inflammation are only partially understood, their impact on all joint-associated tissues is well...
Overview of the Current Osteoarthritis Treatment in Veterinary Medicine and Future Directions.
ACS pharmacology & translational science    April 14, 2026   Volume 9, Issue 5 1037-1054 doi: 10.1021/acsptsci.5c00706
Quintão NLM, Moffa EB, Kroier M, Goldoni RC, Bundgaard L, Jensen AL, Fernandes ES.Osteoarthritis (OA) is a chronic and progressive joint disease that can cause permanent loss of joint function. OA is highly prevalent in horses, dogs, and cats, affecting different joints and leading to reduced mobility and chronic pain. Different risk factors for animal OA have been identified, including trauma and breed. Inflammation is a hallmark of the disease, with various underlying mechanisms such as cyclooxygenase and metalloproteinase activation, nerve growth factor, cytokine, and prostaglandin upregulation, among others. Although disease complexity makes OA difficult to treat, eno...
Successful Use of Vincristine in a Quarter Horse Gelding with Immune-Mediated Thrombocytopenia.
Journal of equine veterinary science    April 8, 2026   105889 doi: 10.1016/j.jevs.2026.105889
Salewski KE, Talavera MA, Gonzalez GA, Waldridge BM, White JM, Williams MJ, Williams ML.This case reports the successful use of vincristine in a Quarter Horse with presumed immune-mediated thrombocytopenia. A 15-year-old Quarter Horse gelding presented for a pinch skin graft procedure on the left forelimb over the cannon bone. On day 10 of hospitalization, the horse developed a fever (102.6°F, RI: 99-101°F), and severe petechiae of the mucous membranes. A complete blood count (CBC) (Advia 2120i) revealed a severe thrombocytopenia (16,000 platelets/μL, RI:100,000-400,000/μL). Diagnostic testing was negative for Anaplasma phagocytophilum by PCR, Theileria equi and Babesia cabal...
Radiation in Veterinary Practice: Paradigm Shift Toward Precision and Curative Approaches.
Life (Basel, Switzerland)    April 8, 2026   Volume 16, Issue 4 626 doi: 10.3390/life16040626
Mârza SM, Munteanu C, Lăcătuş R, Papuc I, Bora FD, Purdoiu RC.Ionizing radiation therapy has undergone a clear paradigm shift in veterinary oncology and inflammatory disease management, moving from mainly palliative use toward structured, curative treatment programs. This review synthesizes current evidence on key modalities used in veterinary practice, including external beam radiotherapy, brachytherapy, systemic targeted radionuclide therapy, stereotactic radiosurgery, stereotactic body radiotherapy, radiosynoviorthesis, and low-dose radiotherapy. Each modality is discussed in relation to its physical and biological basis, major isotopes or beam types,...
In Vitro Characterization of an Equinized Anti-PD-L1 Antibody for Cancer Immunotherapy in Horses.
Veterinary sciences    April 1, 2026   Volume 13, Issue 4 343 doi: 10.3390/vetsci13040343
Horikawa T, Maekawa N, Okagawa T, Tiyamanee W, Ganbaatar O, Nakamura H, Ikehata M, Inoue M, Nakanishi T, Tachibana T, Kato Y, Yamamoto K, Suzuki Y....Horses develop spontaneous tumors, typically in old age. Although local tumor control can be achieved using conventional therapies, systemic therapies are required to treat recurrent and/or metastatic tumors. Immune checkpoint inhibitors, such as anti-PD-L1 antibodies, have been approved for the treatment of various tumor types in humans; however, little is known about the immunosuppressive roles of the PD-1/PD-L1 pathway in horses, and the therapeutic potential of these inhibitors remains to be elucidated. Previously, we reported that the rat monoclonal anti-PD-L1 antibody 6C11-3A11 cross-rea...
Successful resolution of natural Werneckiella equi infestation in two horses using pour-on Fipronil: A clinical observation.
Journal of equine veterinary science    March 20, 2026   105854 doi: 10.1016/j.jevs.2026.105854
Duarte FRSC, Lima FR, Medeiros GC, Furtado LL, Aquino LPCT, Fonteque JH, Moura AB, Chryssafidis AL.Werneckiella equi is an ectoparasite of equids, and control can be challenging because of the limited availability of licensed products. This case report describes the clinical observation of 1% fipronil pour-on against W. equi infestation in horses admitted to a veterinary hospital. Two horses were treated and observed between 2022 and 2023. Both exhibited pruritus, especially in the head, withers, and croup regions, and were diagnosed with severe W. equi infestation. The treatment consisted of a single topical application of 1% fipronil pour-on (1 mg/kg). Parasite reduction was assessed by c...
Global distribution of Neorickettsia risticii, the causative agent of potomac horse fever: a systematic review.
Veterinary research communications    March 18, 2026   Volume 50, Issue 3 205 doi: 10.1007/s11259-026-11146-y
Onyiche TE, Peng TL.Potomac Horse Fever (PHF), also known as equine neorickettsiosis (EN) or equine monocytic ehrlichiosis is an acute, potentially fatal infectious disease in horses caused by the monocytotropic rickettsia bacterium Neorickettsia risticii. This obligate intracellular bacterium is maintained throughout the life cycle of digenetic trematodes which utilize multiple intermediate and definitive hosts. Research on N. risticii is scattered across multiple continents, with most studies originating from North and South America. Therefore, a systematic review is needed to consolidate global evidence, clari...
Sequential Application of Autologous Platelet Rich Plasma and Muscle-Derived Mesenchymal Stem Cells for Acute Tendon Injuries in Horses: Early Clinical and Ultrasonographic Outcomes in a Randomized, Double-Blind Controlled Study.
Animals : an open access journal from MDPI    March 17, 2026   Volume 16, Issue 6 940 doi: 10.3390/ani16060940
Serteyn D, Graide H, Ceusters J, Vandersmissen M, Salciccia A, Sandersen C, Lejeune JP.Tendon and ligament injuries are frequent in sport horses and are prone to recurrence due to incomplete healing. Platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) are increasingly used, but data controlled on the early effects of autologous MSCs remain limited. A prospective randomized, double-blind, placebo-controlled trial was conducted in horses with naturally occurring tendinopathies. After standardized PRP pretreatment, non-responders were randomized to receive intralesional autologous muscle-derived MSCs (mdMSCs, = 17) or placebo ( = 6). Clinical and ultrasonographic paramete...
Equine Protozoal Myeloencephalitis: An Ancient Parasite Meets Modern Compounding.
International journal of pharmaceutical compounding    March 13, 2026   Volume 30, Issue 1 23-25 
Bethel M.EPM remains particularly rampant in racing populations due to transport stress, young age, and congregate housing conditions. For compounding pharmacists, understanding that we're managing chronic parasite suppression - not achieving cure - fundamentally changes our approach to formulation strategy, stability assessment, and client counseling. The two formulations presented separately represent years of refinement, demonstrating compounding's essential role when commercial products fall short.
Topical treatment of equine aural plaques with nitric acid and zinc solution.
Equine veterinary journal    March 12, 2026   doi: 10.1002/evj.70161
Leo LK, Bergvall KE.Equine aural plaque caused by equine papilloma viruses is common worldwide and affected horses can show severe clinical signs. Due to its viral aetiology, in some countries affected horses are not allowed to compete. Since lesions persist, showing no spontaneous regression, effective and safe treatment is required. Currently, the only treatment with consistent efficacy is imiquimod. Treatment time is prolonged and adverse effects are common. In humans, papilloma warts are successfully and safely treated with topical nitric-zinc complex solutions inducing a painless caustic effect. Objective: T...
Photodynamic therapy with infracyanine green induces keratocyte depopulation in the normal equine cornea.
Equine veterinary journal    March 8, 2026   doi: 10.1002/evj.70159
Rogers CM, Ledbetter EC, Reid AM, Scott EM, Knickelbein KE.Use of photodynamic therapy (PDT) for the treatment of immune-mediated keratitis (IMMK) in horses is becoming common. The safety and morphologic impact on the normal equine cornea have not been investigated, and the mechanism of its efficacy is unknown. Objective: To investigate the morphologic effects and safety of in vivo PDT on healthy equine corneas. Methods: In vivo experiment. Methods: Six university-owned horses underwent unilateral corneal PDT with intrastromal infracyanine green (EmunDo®) and photoactivation with an 810 nm diode laser (500 mW for 2.5 min = 75 Joules). Compl...
Equine neorickettsiosis: A global perspective of the natural habitat of the bacteria and clinical disease.
Veterinary microbiology    March 6, 2026   Volume 316 110963 doi: 10.1016/j.vetmic.2026.110963
Arroyo LG, Borges AS, Baird JD, Perry BD, Rikihisa Y, Greiman SE.Equine neorickettsiosis (EN) is an infectious, non-contagious systemic disease of horses caused by the closely related obligatory intracellular bacterial species Neorickettsia risticii and N. findlayensis. Clinical cases are considered endemic in multiple regions across the United States and Canada, as well as in parts of South America, including Uruguay and Brazil. Neorickettsia spp. are obligate endosymbionts of digenean trematodes, which have complex life cycles involving a molluscan first intermediate host, a wide range of invertebrate or vertebrate second intermediate hosts, and a vertebr...
Survey on Faecal Microbiota Transplantation and Probiotic Use in Equine Practice in France and Belgium.
Veterinary medicine and science    March 5, 2026   Volume 12, Issue 2 e70854 doi: 10.1002/vms3.70854
Loublier C, Taminiau B, Seidel L, Moula N, Tano C, Cesarini C, Costa M, Lecoq L, Daube G, Amory H.Faecal microbiota transplantation (FMT) and probiotics are used in equine practice. Understanding veterinarians' perceptions and practices is crucial for effective implementation. Objective: (1) Evaluate the prevalence, usage patterns and perceived effectiveness of probiotics and FMT among equine veterinarians in France and Belgium. (2) Assess their knowledge, practices and influencing factors across demographics and settings. (3) Explore links between FMT protocols and treatment satisfaction. Methods: Cross-sectional survey. Methods: An online survey collected demographic data and responses o...
Horse immune response of recombinant Lawsonia intracellularis vaccine: Assessing the immunomodulatory impact of probiotic supplementation.
Research in veterinary science    March 2, 2026   Volume 204 106132 doi: 10.1016/j.rvsc.2026.106132
Conrad NL, Mazzoleni I, Abreu MC, Costa AV, Di Giácomo CP, Zorzi VSG, Leite FPL.Equine proliferative enteropathy (EPE), caused by Lawsonia intracellularis induces intestinal epithelial hyperplasia, resulting in malabsorption, weight loss, colic, and diarrhea. Despite its clinical and economic importance, no equine-specific vaccine is commercially available. Recombinant subunit vaccines are a safe and scalable alternative; however, their immunogenicity often requires improvement. Probiotic supplementation with Bacillus toyonensis may act as an immunomodulatory strategy to potentiate vaccine efficacy. This study aimed to evaluate the immunogenicity of a recombinant protein ...
Systematic review and meta-analysis of adult multipotent stromal/stem cell treatment for equine tendinopathy and desmopathy.
Frontiers in veterinary science    March 2, 2026   Volume 13 1758586 doi: 10.3389/fvets.2026.1758586
Taguchi T, Lopez MJ, Aoun R, Helber L.Over the last few decades, cell and cell-based therapies emerged as treatment options for equine tendinopathy and desmopathy. The objective of this study was to critically evaluate outcomes following treatment of equine tendinopathy or desmopathy with adult multipotent stromal/stem cells (MSCs). Unassigned: The PubMed and Web of Science databases were searched for "equine/horse," "tendon/tendinopathy/tendonitis/ligament/ligamentopathy/desmopathy/desmitis," "stem/stromal/mesenchymal/multipotent," and "cell" from January 2001 to June 2025. Studies were identified according to PRISMA guidelines, ...
Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells.
Journal of veterinary internal medicine    February 26, 2026   Volume 40, Issue 1 aalaf015 doi: 10.1093/jvimsj/aalaf015
Semik-Gurgul E, Ocłoń E, Zubel-Łojek J, Pędziwiatr R, Pawlina-Tyszko K.Sarcoids are locally invasive skin tumors in equids, associated with bovine papillomavirus. Objective: Address potential applications of cannabidiol (CBD) in veterinary medicine. We evaluated the response of equine sarcoid cells to CBD in vitro, focusing on viability, invasiveness, and matrix remodeling. Methods: Three primary sarcoid cell lines. Methods: Cells were treated with CBD (20, 6.75, 2.25, 0.75 μM) and incubated for 6, 24, 48, 72 hours. Cell viability, cytotoxicity, and apoptosis were assessed using the ApoTox-Glo Assay. Based on these results, further analyses were performed for ...
Updates on Seizures and Epilepsy in the Horse.
The Veterinary clinics of North America. Equine practice    February 25, 2026   S0749-0739(25)00077-X doi: 10.1016/j.cveq.2025.12.009
Migliorisi A.The goal of this article is to provide the equine practitioners with a framework for a diagnostic algorithm for the patient presented with possible seizures/epilepsy. Using a comparative approach, a review of companion animal and human research is provided with the intention of expanding our current knowledge on seizure/epilepsy, as well as diagnostic and treatment strategies for equine patients.
Clinical and research applications of synthetic bone substitutes in equine veterinary medicine: A systematic review.
Equine veterinary journal    February 24, 2026   doi: 10.1002/evj.70151
Skierbiszewska K, Turek B, Jasiński T, Kaczorowski M, Kozłowska N, Higuchi J, Domino M.Bone grafting in equine medicine offers a promising contribution to treating orthopaedic developmental diseases and chondral, osteochondral and segmental bone defects. Among grafts, synthetic bone substitutes-alloplastics-show favourable biological properties addressing numerous limitations presented by autografts, xenografts and allografts. Objective: To compile and disseminate clinical data and research findings from existing publications on the use of alloplastics in horses. Methods: Systematic review. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-analysis 202...
Antibiofilm and resistance-modulating properties of tt-farnesol against Streptococcus equi subsp. equi and zooepidemicus.
Microbial pathogenesis    February 24, 2026   Volume 214 108407 doi: 10.1016/j.micpath.2026.108407
Pereira Lopes A, Emanuel da Silva R, Sousa Santos L, de Morais Nobre ML, de Araujo Sousa PS, Almeida Rocha J, Veras Quelemes P, de Araujo-Nobre AR....The aim of this study was to investigate the antibacterial, antibiofilm and modulating activities of trans-trans-farnesol (tt-farnesol) on two strains of Streptococcus equi subsp. equi and two strains of S. equi subsp. zooepidemicus, pathogenic or commensal bacteria of horses. Tt-farnesol showed bactericidal activity against all tested strains, with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) between 8 and 4 μg/mL. The sesquiterpene caused significant damage to the bacterial membrane, and its antibacterial activity did not appear to depend on oxidat...
Obtention and preliminary clinical evaluation of an equine albumin for intravenous administration in adult Colombian Creole Horses (Equus ferus caballus).
PloS one    February 20, 2026   Volume 21, Issue 2 e0341577 doi: 10.1371/journal.pone.0341577
Cifuentes V, Zuluaga-Cabrera AM, Vargas-Muñoz LJ, Estrada-Gómez S.Albumin is one of the most abundant and physiologically important blood protein in horses due to its ability to regulate vascular volume and transport blood metabolites or drugs. Despite the importance of this protein, in Colombia there is no previous reference of the use of equine albumin in horses as a pharmacological therapy and there is no available any pharmaceutical preparation of this protein to be administrated in horses. This study aims to evaluate for first time the preliminary clinical response of healthy adult Colombian Creole horses after the intravenous administration of an equin...
1 2 3 581